新年到來之際，美國製藥公司上調了數百種藥品價格，艾爾建(Allergan Inc., AGN)旗下20多種藥品售價提高近10%。由於公眾和政界就藥價問題向製藥行業施加更大壓力，今年許多公司的提價幅度較為溫和。不過，包括一些仿製藥在內的少數藥品提價幅度非常高。美國所開處方中有90%都是可替代品牌藥的較低價仿製藥。包括輝瑞製藥有限公司(Pfizer Inc., PFE)最近恢復的提價在內，總體來看藥價漲幅仍高於通脹率。據Rx Savings Solutions的分析顯示，美國30多家製藥商週二提高了數百種藥品價格，平均漲幅為6.3%，包括同一種藥品不同劑量的漲幅。Rx Savings Solutions出售的軟體可以説明雇主和醫療計畫選擇最便宜藥品。
Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan AGN setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis. Many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S. Overall, price increases, including recently restored price increases from Pfizer Inc., PFE 1.61% continue to exceed inflation. More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines. The average increase was 6.3%, according to the analysis, including increases on different doses for the same drug.
艾爾建證實了上述分析中提到的藥品漲價，稱該公司提高了51種藥品的價格，其中27種漲價約9.5%，其餘24種漲價約4.9%。漲價藥品覆蓋了該公司逾一半的產品組合，包括阿茲海默症治療藥物Namenda的延長釋放版本以及乾眼症治療藥物Restasis。根據此項分析，在上述公司漲價幅度超過9%的藥品中，艾爾建的產品占最多數。
Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan AGN setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis. Many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S. Overall, price increases, including recently restored price increases from Pfizer Inc., PFE 1.61% continue to exceed inflation. More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines. The average increase was 6.3%, according to the analysis, including increases on different doses for the same drug.
艾爾建證實了上述分析中提到的藥品漲價，稱該公司提高了51種藥品的價格，其中27種漲價約9.5%，其餘24種漲價約4.9%。漲價藥品覆蓋了該公司逾一半的產品組合，包括阿茲海默症治療藥物Namenda的延長釋放版本以及乾眼症治療藥物Restasis。根據此項分析，在上述公司漲價幅度超過9%的藥品中，艾爾建的產品占最多數。
最新評論